Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma

Completed · Phase 2

Conditions studied: Stage IV Melanoma, Recurrent Melanoma

In brief

RATIONALE: Interferon beta may interfere with the growth of tumor cells. PURPOSE: This phase II trial is studying how well interferon beta works in treating patients with metastatic cutaneous (skin) melanoma or ocular (eye) melanoma.

Key facts

Study ID

NCT00085306

Run by

Case Comprehensive Cancer Center

People needed

21

Starts

2004-04-01

Expected to finish

2007-10-01

Last updated by the study team

2015-10-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.